カテゴリ： 世界, 医療/バイオ, QYResearch

ペット用腸薬の世界市場2023年：粉末、液体

■ 英語タイトル：Global Pet Intestinal Medicine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8249）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8249
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ペット用腸薬の世界市場2023年：粉末、液体]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はペット用腸薬のグローバル市場について調査・分析し、世界のペット用腸薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（粉末、液体）、用途別セグメント分析（猫、犬、爬虫類、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHICなどが含まれています。ペット用腸薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ペット用腸薬市場規模を算出する際に考慮しました。

・ペット用腸薬市場の概要
- 製品の定義
- ペット用腸薬の種類別セグメント
- 世界のペット用腸薬市場規模：タイプ別分析（粉末、液体）
- ペット用腸薬の用途別セグメント
- 世界のペット用腸薬市場規模：用途別分析（猫、犬、爬虫類、その他）
- 世界のペット用腸薬市場規模予測（2018年-2029年）
- ペット用腸薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ペット用腸薬市場の競争状況およびトレンド

・ペット用腸薬の地域別市場規模
- 北米のペット用腸薬市場規模（2018年-2029年）
- 米国のペット用腸薬市場規模（2018年-2029年）
- ヨーロッパのペット用腸薬市場規模（2018年-2029年）
- アジア太平洋のペット用腸薬市場規模（2018年-2029年）
- 中国のペット用腸薬市場規模（2018年-2029年）
- 日本のペット用腸薬市場規模（2018年-2029年）
- 韓国のペット用腸薬市場規模（2018年-2029年）
- インドのペット用腸薬市場規模（2018年-2029年）
- オーストラリアのペット用腸薬市場規模（2018年-2029年）
- 中南米のペット用腸薬市場規模（2018年-2029年）
- 中東・アフリカのペット用腸薬市場規模（2018年-2029年）

・種類別セグメント：粉末、液体
- 世界のペット用腸薬のタイプ別販売量（2018年-2023年）
- 世界のペット用腸薬のタイプ別売上（2018年-2023年）
- 世界のペット用腸薬のタイプ別価格

・用途別セグメント：猫、犬、爬虫類、その他
- 世界のペット用腸薬の用途別販売量（2018年-2023年）
- 世界のペット用腸薬の用途別売上（2018年-2023年）
- 世界のペット用腸薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHIC

・産業チェーンと販売チャネルの分析
- ペット用腸薬産業チェーン分析
- ペット用腸薬の主要原材料
- ペット用腸薬の販売チャネル
- ペット用腸薬のディストリビューター
- ペット用腸薬の主要顧客

・ペット用腸薬市場ダイナミクス
- ペット用腸薬の業界動向
- ペット用腸薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
Highlights
The global Pet Intestinal Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Pet Intestinal Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pet Intestinal Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Pet Intestinal Medicine include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Intestinal Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Intestinal Medicine.
The Pet Intestinal Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pet Intestinal Medicine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Intestinal Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Segment by Type
Powder
Liquid
Segment by Application
Cat
Dog
Reptile
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Intestinal Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Intestinal Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Pet Intestinal Medicine Market Overview
1.1 Product Overview and Scope of Pet Intestinal Medicine
1.2 Pet Intestinal Medicine Segment by Type
1.2.1 Global Pet Intestinal Medicine Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Liquid
1.3 Pet Intestinal Medicine Segment by Application
1.3.1 Global Pet Intestinal Medicine Market Value by Application: (2023-2029)
1.3.2 Cat
1.3.3 Dog
1.3.4 Reptile
1.3.5 Other
1.4 Global Pet Intestinal Medicine Market Size Estimates and Forecasts
1.4.1 Global Pet Intestinal Medicine Revenue 2018-2029
1.4.2 Global Pet Intestinal Medicine Sales 2018-2029
1.4.3 Global Pet Intestinal Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pet Intestinal Medicine Market Competition by Manufacturers
2.1 Global Pet Intestinal Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pet Intestinal Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pet Intestinal Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Pet Intestinal Medicine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pet Intestinal Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Intestinal Medicine, Product Type & Application
2.7 Pet Intestinal Medicine Market Competitive Situation and Trends
2.7.1 Pet Intestinal Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Intestinal Medicine Players Market Share by Revenue
2.7.3 Global Pet Intestinal Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Intestinal Medicine Retrospective Market Scenario by Region
3.1 Global Pet Intestinal Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pet Intestinal Medicine Global Pet Intestinal Medicine Sales by Region: 2018-2029
3.2.1 Global Pet Intestinal Medicine Sales by Region: 2018-2023
3.2.2 Global Pet Intestinal Medicine Sales by Region: 2024-2029
3.3 Global Pet Intestinal Medicine Global Pet Intestinal Medicine Revenue by Region: 2018-2029
3.3.1 Global Pet Intestinal Medicine Revenue by Region: 2018-2023
3.3.2 Global Pet Intestinal Medicine Revenue by Region: 2024-2029
3.4 North America Pet Intestinal Medicine Market Facts & Figures by Country
3.4.1 North America Pet Intestinal Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pet Intestinal Medicine Sales by Country (2018-2029)
3.4.3 North America Pet Intestinal Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Intestinal Medicine Market Facts & Figures by Country
3.5.1 Europe Pet Intestinal Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pet Intestinal Medicine Sales by Country (2018-2029)
3.5.3 Europe Pet Intestinal Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Intestinal Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Intestinal Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pet Intestinal Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Pet Intestinal Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet Intestinal Medicine Market Facts & Figures by Country
3.7.1 Latin America Pet Intestinal Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pet Intestinal Medicine Sales by Country (2018-2029)
3.7.3 Latin America Pet Intestinal Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pet Intestinal Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Intestinal Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pet Intestinal Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pet Intestinal Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Intestinal Medicine Sales by Type (2018-2029)
4.1.1 Global Pet Intestinal Medicine Sales by Type (2018-2023)
4.1.2 Global Pet Intestinal Medicine Sales by Type (2024-2029)
4.1.3 Global Pet Intestinal Medicine Sales Market Share by Type (2018-2029)
4.2 Global Pet Intestinal Medicine Revenue by Type (2018-2029)
4.2.1 Global Pet Intestinal Medicine Revenue by Type (2018-2023)
4.2.2 Global Pet Intestinal Medicine Revenue by Type (2024-2029)
4.2.3 Global Pet Intestinal Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Pet Intestinal Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pet Intestinal Medicine Sales by Application (2018-2029)
5.1.1 Global Pet Intestinal Medicine Sales by Application (2018-2023)
5.1.2 Global Pet Intestinal Medicine Sales by Application (2024-2029)
5.1.3 Global Pet Intestinal Medicine Sales Market Share by Application (2018-2029)
5.2 Global Pet Intestinal Medicine Revenue by Application (2018-2029)
5.2.1 Global Pet Intestinal Medicine Revenue by Application (2018-2023)
5.2.2 Global Pet Intestinal Medicine Revenue by Application (2024-2029)
5.2.3 Global Pet Intestinal Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Pet Intestinal Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Pet Intestinal Medicine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Pet Intestinal Medicine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Pet Intestinal Medicine Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Pet Intestinal Medicine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Pet Intestinal Medicine Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Vetoquinol Pet Intestinal Medicine Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Corporation Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ouro Fino Saude Pet Intestinal Medicine Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Corporation Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Norbrook Pet Intestinal Medicine Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Corporation Information
6.11.2 Jindun Pet Intestinal Medicine Description and Business Overview
6.11.3 Jindun Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jindun Pet Intestinal Medicine Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Wuhan chopperlvya
6.12.1 Wuhan chopperlvya Corporation Information
6.12.2 Wuhan chopperlvya Pet Intestinal Medicine Description and Business Overview
6.12.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio
6.12.5 Wuhan chopperlvya Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Pet Intestinal Medicine Description and Business Overview
6.13.3 CAHIC Pet Intestinal Medicine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CAHIC Pet Intestinal Medicine Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Intestinal Medicine Industry Chain Analysis
7.2 Pet Intestinal Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Intestinal Medicine Production Mode & Process
7.4 Pet Intestinal Medicine Sales and Marketing
7.4.1 Pet Intestinal Medicine Sales Channels
7.4.2 Pet Intestinal Medicine Distributors
7.5 Pet Intestinal Medicine Customers
8 Pet Intestinal Medicine Market Dynamics
8.1 Pet Intestinal Medicine Industry Trends
8.2 Pet Intestinal Medicine Market Drivers
8.3 Pet Intestinal Medicine Market Challenges
8.4 Pet Intestinal Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Pet Intestinal Medicine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Pet Intestinal Medicine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Pet Intestinal Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pet Intestinal Medicine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Pet Intestinal Medicine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Pet Intestinal Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Pet Intestinal Medicine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Pet Intestinal Medicine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Pet Intestinal Medicine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Pet Intestinal Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Intestinal Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Pet Intestinal Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Intestinal Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Intestinal Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Intestinal Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Pet Intestinal Medicine Sales by Region (2018-2023) & (K Units)
Table 18. Global Pet Intestinal Medicine Sales Market Share by Region (2018-2023)
Table 19. Global Pet Intestinal Medicine Sales by Region (2024-2029) & (K Units)
Table 20. Global Pet Intestinal Medicine Sales Market Share by Region (2024-2029)
Table 21. Global Pet Intestinal Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Pet Intestinal Medicine Revenue Market Share by Region (2018-2023)
Table 23. Global Pet Intestinal Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Pet Intestinal Medicine Revenue Market Share by Region (2024-2029)
Table 25. North America Pet Intestinal Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Pet Intestinal Medicine Sales by Country (2018-2023) & (K Units)
Table 27. North America Pet Intestinal Medicine Sales by Country (2024-2029) & (K Units)
Table 28. North America Pet Intestinal Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Pet Intestinal Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Pet Intestinal Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Pet Intestinal Medicine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Pet Intestinal Medicine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Pet Intestinal Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Pet Intestinal Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Pet Intestinal Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Pet Intestinal Medicine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Pet Intestinal Medicine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Pet Intestinal Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Pet Intestinal Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Pet Intestinal Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Pet Intestinal Medicine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Pet Intestinal Medicine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Pet Intestinal Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pet Intestinal Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Pet Intestinal Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Pet Intestinal Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Pet Intestinal Medicine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Pet Intestinal Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Pet Intestinal Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Pet Intestinal Medicine Sales (K Units) by Type (2018-2023)
Table 51. Global Pet Intestinal Medicine Sales (K Units) by Type (2024-2029)
Table 52. Global Pet Intestinal Medicine Sales Market Share by Type (2018-2023)
Table 53. Global Pet Intestinal Medicine Sales Market Share by Type (2024-2029)
Table 54. Global Pet Intestinal Medicine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Pet Intestinal Medicine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Pet Intestinal Medicine Revenue Market Share by Type (2018-2023)
Table 57. Global Pet Intestinal Medicine Revenue Market Share by Type (2024-2029)
Table 58. Global Pet Intestinal Medicine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Pet Intestinal Medicine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Pet Intestinal Medicine Sales (K Units) by Application (2018-2023)
Table 61. Global Pet Intestinal Medicine Sales (K Units) by Application (2024-2029)
Table 62. Global Pet Intestinal Medicine Sales Market Share by Application (2018-2023)
Table 63. Global Pet Intestinal Medicine Sales Market Share by Application (2024-2029)
Table 64. Global Pet Intestinal Medicine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Pet Intestinal Medicine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Pet Intestinal Medicine Revenue Market Share by Application (2018-2023)
Table 67. Global Pet Intestinal Medicine Revenue Market Share by Application (2024-2029)
Table 68. Global Pet Intestinal Medicine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Pet Intestinal Medicine Price (US$/Unit) by Application (2024-2029)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Zoetis Pet Intestinal Medicine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Boehringer Ingelheim Pet Intestinal Medicine Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck Pet Intestinal Medicine Product
Table 84. Merck Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Elanco Pet Intestinal Medicine Product
Table 89. Elanco Recent Developments/Updates
Table 90. Virbac Corporation Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Virbac Pet Intestinal Medicine Product
Table 94. Virbac Recent Developments/Updates
Table 95. Dechra Veterinary Products Corporation Information
Table 96. Dechra Veterinary Products Description and Business Overview
Table 97. Dechra Veterinary Products Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Dechra Veterinary Products Pet Intestinal Medicine Product
Table 99. Dechra Veterinary Products Recent Developments/Updates
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ceva Pet Intestinal Medicine Product
Table 104. Ceva Recent Developments/Updates
Table 105. Vetoquinol Corporation Information
Table 106. Vetoquinol Description and Business Overview
Table 107. Vetoquinol Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Vetoquinol Pet Intestinal Medicine Product
Table 109. Vetoquinol Recent Developments/Updates
Table 110. Ouro Fino Saude Corporation Information
Table 111. Ouro Fino Saude Description and Business Overview
Table 112. Ouro Fino Saude Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Ouro Fino Saude Pet Intestinal Medicine Product
Table 114. Ouro Fino Saude Recent Developments/Updates
Table 115. Norbrook Corporation Information
Table 116. Norbrook Description and Business Overview
Table 117. Norbrook Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Norbrook Pet Intestinal Medicine Product
Table 119. Norbrook Recent Developments/Updates
Table 120. Jindun Corporation Information
Table 121. Jindun Description and Business Overview
Table 122. Jindun Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Jindun Pet Intestinal Medicine Product
Table 124. Jindun Recent Developments/Updates
Table 125. Wuhan chopperlvya Corporation Information
Table 126. Wuhan chopperlvya Description and Business Overview
Table 127. Wuhan chopperlvya Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Wuhan chopperlvya Pet Intestinal Medicine Product
Table 129. Wuhan chopperlvya Recent Developments/Updates
Table 130. CAHIC Corporation Information
Table 131. CAHIC Description and Business Overview
Table 132. CAHIC Pet Intestinal Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. CAHIC Pet Intestinal Medicine Product
Table 134. CAHIC Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Pet Intestinal Medicine Distributors List
Table 138. Pet Intestinal Medicine Customers List
Table 139. Pet Intestinal Medicine Market Trends
Table 140. Pet Intestinal Medicine Market Drivers
Table 141. Pet Intestinal Medicine Market Challenges
Table 142. Pet Intestinal Medicine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Intestinal Medicine
Figure 2. Global Pet Intestinal Medicine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Pet Intestinal Medicine Market Share by Type in 2022 & 2029
Figure 4. Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Pet Intestinal Medicine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Pet Intestinal Medicine Market Share by Application in 2022 & 2029
Figure 8. Cat
Figure 9. Dog
Figure 10. Reptile
Figure 11. Other
Figure 12. Global Pet Intestinal Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Pet Intestinal Medicine Market Size (2018-2029) & (US$ Million)
Figure 14. Global Pet Intestinal Medicine Sales (2018-2029) & (K Units)
Figure 15. Global Pet Intestinal Medicine Average Price (US$/Unit) & (2018-2029)
Figure 16. Pet Intestinal Medicine Report Years Considered
Figure 17. Pet Intestinal Medicine Sales Share by Manufacturers in 2022
Figure 18. Global Pet Intestinal Medicine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Pet Intestinal Medicine Players: Market Share by Revenue in 2022
Figure 20. Pet Intestinal Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Pet Intestinal Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Pet Intestinal Medicine Sales Market Share by Country (2018-2029)
Figure 23. North America Pet Intestinal Medicine Revenue Market Share by Country (2018-2029)
Figure 24. United States Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Pet Intestinal Medicine Sales Market Share by Country (2018-2029)
Figure 27. Europe Pet Intestinal Medicine Revenue Market Share by Country (2018-2029)
Figure 28. Germany Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Pet Intestinal Medicine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Pet Intestinal Medicine Revenue Market Share by Region (2018-2029)
Figure 35. China Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Pet Intestinal Medicine Sales Market Share by Country (2018-2029)
Figure 45. Latin America Pet Intestinal Medicine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Pet Intestinal Medicine Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Pet Intestinal Medicine Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Pet Intestinal Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Pet Intestinal Medicine by Type (2018-2029)
Figure 56. Global Revenue Market Share of Pet Intestinal Medicine by Type (2018-2029)
Figure 57. Global Pet Intestinal Medicine Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Pet Intestinal Medicine by Application (2018-2029)
Figure 59. Global Revenue Market Share of Pet Intestinal Medicine by Application (2018-2029)
Figure 60. Global Pet Intestinal Medicine Price (US$/Unit) by Application (2018-2029)
Figure 61. Pet Intestinal Medicine Value Chain
Figure 62. Pet Intestinal Medicine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 腸鉗子の世界市場2023年：ストレート型、ベンド型
  • チベット医薬品の世界市場2023年：内服薬、絆創膏
  • 歯科用睡眠装置の世界市場2023年：下顎前方移動装置、マウスガード、舌保持装置
  • 動物用腸内環境医療のグローバル市場展望 2023年-2029年：プロバイオティクス、プレバイオティクス、植物源、免疫賦活剤
  • 白芍藥TCM煎じ薬の世界市場2023年：フレーク式、バー式
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8249 )"ペット用腸薬の世界市場2023年：粉末、液体" (英文：Global Pet Intestinal Medicine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。